Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06599229 · ClinicalTrials.gov registry record
Perfusion Abnormalities in Hypertrophic Cardiomyopathy
A clinical trial, sponsored by University of Virginia.
- Active
- Registry status
- 30
- Enrollment target
NCT06599229 is a clinical trial that is active but no longer recruiting, run by University of Virginia. The registered enrollment target is 30 participants.
The verdict
NCT06599229 is active but no longer recruiting, sponsored by University of Virginia.
- ACTIVE NOT RECRUITING
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether myocardial microvascular perfusion in patients with hypertrophic cardiomyopathy improved after initiation of cardiac myosin inhibitor therapy.
Interventions
- DIAGNOSTIC_TEST myocardial contrast echo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-01-02 |
| Est. Completion | 2026-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06599229
The ClinicalTrials.gov registry entry for NCT06599229 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which myocardial contrast echo is the first listed.
NCT06599229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06599229 about?
NCT06599229 is a clinical study titled "Perfusion Abnormalities in Hypertrophic Cardiomyopathy". The purpose of this study is to investigate whether myocardial microvascular perfusion in patients with hypertrophic cardiomyopathy improved after initiation of cardiac myosin inhibitor therapy.
What is the current status of trial NCT06599229?
This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2025-01-02. Estimated completion is 2026-12-01.
What interventions are being tested in trial NCT06599229?
The interventions under investigation include: myocardial contrast echo (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06599229?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.